Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery

ClinicalTrials.gov ID: NCT00679588

Public ClinicalTrials.gov record NCT00679588. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 12:06 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multinational, Multicenter, Randomized, Double Blind Study Comparing the Efficacy and Safety of AVE5026 With Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery

Study identification

NCT ID
NCT00679588
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sanofi
Industry
Enrollment
4,413 participants

Conditions and interventions

Interventions

  • Semuloparin Sodium Drug
  • Enoxaparin sodium Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2008
Primary completion
Jul 31, 2010
Completion
Jul 31, 2010
Last update posted
Dec 15, 2013

2008 – 2010

United States locations

U.S. sites
25
U.S. states
13
U.S. cities
21
Facility City State ZIP Site status
Investigational Site Number 840026 Birmingham Alabama 35209
Investigational Site Number 840035 Birmingham Alabama 35209
Investigational Site Number 840042 Birmingham Alabama 35209
Investigational Site Number 840002 Birmingham Alabama 35234
Investigational Site Number 840031 Corlton California 82324
Investigational Site Number 840007 Huntingdon Beach California 92647
Investigational Site Number 840014 Los Angeles California 90033
Investigational Site Number 840011 Sant Barbara California 93105
Investigational Site Number 840021 Denver Colorado 80262
Investigational Site Number 840029 Clearwater Florida 33756
Investigational Site Number 840017 Jacksonville Florida 32209
Investigational Site Number 840044 Miami Florida 33136
Investigational Site Number 840015 Orlando Florida 32804
Investigational Site Number 840009 Columbus Georgia 31904
Investigational Site Number 840019 Maywood Illinois 60153
Investigational Site Number 840036 Springfield Illinois 62702
Investigational Site Number 840037 Hazard Kentucky 41701
Investigational Site Number 840008 St Louis Missouri 63104
Investigational Site Number 840020 Teaneck New Jersey 07666
Investigational Site Number 840051 Columbus Ohio 43210
Investigational Site Number 840006 Pittsburgh Pennsylvania 15240
Investigational Site Number 840025 Houston Texas 77024
Investigational Site Number 840050 Houston Texas 77070
Investigational Site Number 840032 Lubbock Texas 79409
Investigational Site Number 840043 Morgantown West Virginia 26506

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 245 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00679588, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 15, 2013 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00679588 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →